Resources
Download Now: Optimization, Scale-up, and GMP Manufacturing of a Polymer-Drug Conjugate
Form
Fill Out The Form To Begin Your Download

A biotech company developing a polymer-drug conjugate (PDC) for parenteral use needed a partner to support their transition to clinical trials. They required expertise in process development, scale-up, and GMP-compliant manufacturing. Curapath met these needs with a comprehensive approach, ensuring efficiency and quality at every stage. Learn more about how Curapath met the needs of this client by accessing the full document..
Resources
pSar White Paper
Polysarcosine (pSar), a safer, more effective alternative to poly-ethylene glycol (PEG)

Support for Your Therapeutic Program
Contact a Chemist Today
Contact Us, and we can discuss your specific therapeutic program and how Curapath can help build the right solution to advance your unique drug.